GreenLight Biosciences Holdings, PBC
PrivateLast Round
Series C
Mar 26, 2025
Est. Valuation
$45.5M
Total Funding Raised
$324.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GreenLight Biosciences Holdings, PBC operates in Healthcare & Life Sciences and is based in Medford, Massachusetts. Its latest recorded funding round was a Series C round in March 2025.
GreenLight Biosciences Holdings, PBC is a biotechnology company that has a cell-free ribonucleic acid (RNA) production platform for the discovery, development, and commercialization of products for plant and human health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GreenLight Biosciences Holdings, PBC Comparables
Compare GreenLight Biosciences Holdings, PBC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vestaron | 82% | |
| Terrana Biosciences | 80% | |
| RNAissance Ag | 78% |
For institutional investors. Book with your work email.
GreenLight Biosciences Holdings, PBC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 26, 2025 | ||||
| Take Private | May 30, 2023 | ||||
| Private Placement | Aug 12, 2022 | ||||
| PIPE | Feb 2, 2022 | ||||
| Series D | Jun 16, 2020 | ||||
Convertible Debt | Apr 22, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GreenLight Biosciences Holdings, PBC Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Xeraya Capital | Convertible Debt, PIPE, Series C |
| SymBiosis Capital Management | Private Placement |
| Flu Lab | Convertible Debt |
| Just Climate | Series C |
| Fall Line Capital | PIPE, Private Placement, Series D, Take Private |
| Furneaux Capital | Series D |
| Khosla Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 39% MoM, reaching 3.3K.
- Mar 26, 2025
$25M round led by Just Climate.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 13, 2026
GreenLight Biosciences, Inc. attends the 2026 Ontario Pest Management Conference, where its Development & Tech Services Consultant Wayne Barton is set to explore RNA interference as an emerging crop-protection technology.
- expands_facilitiesAug 25, 2026
GreenLight Biosciences, Inc. plans to invest between US$50 million and US$100 million in a production facility in Mexico City, creating more than 500 specialized jobs.
- invests_into_assetsAug 25, 2026
GreenLight Biosciences, Inc. plans to invest $75M in a production facility in Mexico to build local production capacity for RNA-based agricultural technologies.
For institutional investors. Book with your work email.
GreenLight Biosciences Holdings, PBC Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GreenLight Biosciences Holdings, PBC's valuation, stock price, and market status.
Is GreenLight Biosciences Holdings, PBC a public or private company?
GreenLight Biosciences Holdings, PBC is a private company.
What is the current stock price of GreenLight Biosciences Holdings, PBC?
GreenLight Biosciences Holdings, PBC is a private company, so its shares have no public market price. Caplight tracks GreenLight Biosciences Holdings, PBC's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GreenLight Biosciences Holdings, PBC worth (valuation)?
GreenLight Biosciences Holdings, PBC's valuation is estimated at $45.5M based on funding round data.
Can I buy GreenLight Biosciences Holdings, PBC stock?
GreenLight Biosciences Holdings, PBC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GreenLight Biosciences Holdings, PBC's last funding round?
GreenLight Biosciences Holdings, PBC's most recent funding round was Series C on March 26, 2025.
Who are the main investors in GreenLight Biosciences Holdings, PBC?
Key investors in GreenLight Biosciences Holdings, PBC include Fall Line Capital, Morningside Ventures, BlueIO, Baird Capital, S2G Investments.
Will GreenLight Biosciences Holdings, PBC IPO soon?
No public IPO plans have been announced for GreenLight Biosciences Holdings, PBC.
How can I track GreenLight Biosciences Holdings, PBC secondary market activity?
Caplight tracks bids, offers, and trades in GreenLight Biosciences Holdings, PBC's shares on secondary markets.